Development, characterization, and toxicity evaluation of amphotericin B–loaded gelatin nanoparticles
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Protein-based nanocarriers as promising drug and gene delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.036 · Cited by 852
Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy
Lohcharoenkal, W., Wang, L., Chen, Y. C., & Rojanasakul, Y. (2014) · BioMed Research International · doi:10.1155/2014/180549 · Cited by 655
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
Elzoghby, A. O. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.019 · Cited by 651
Recent advancement of gelatin nanoparticles in drug and vaccine delivery
Sahoo, N., Sahoo, R. K., Biswas, N., Guha, A., & Kuotsu, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.006 · Cited by 270
A review of glycosylated carriers for drug delivery
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.033 · Cited by 253
Self-citationSoliman, G. M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.019 · Cited by 203
“Different types of gelatin (Type A and B) were used to prepare NPs by the two-step desolvation method to control AmB delivery and reduce its toxicity (Nahar et al., 2008).”
MethodGelatin nanoparticles: a potential candidate for medical applications
Yasmin, R., Shah, M., Khan, S. A., & Ali, R. (2017) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0009 · Cited by 195
Sabra, S. A., Elzoghby, A. O., Sheweita, S. A., Haroun, M., Helmy, M. W., Eldemellawy, M. A., Xia, Y., Goodale, D., Allan, A. L., & Rohani, S. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.023 · Cited by 170
Oliveira, C. A. D., Peres, D. D., Graziola, F., Chacra, N. A. B., Araújo, G. L. B. D., Flórido, A. C., Mota, J., Rosado, C., Velasco, M. V. R., Rodrigues, L. M., et al. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.09.016 · Cited by 118
Safety and efficacy evaluation of gelatin-based nanoparticles associated with UV filters
Oliveira, C. A. D., Dario, M. F., Sarruf, F. D., Mariz, I. F. A., Velasco, M. V. R., Rosado, C., & Baby, A. R. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2015.11.031 · Cited by 54
Gelatin-based microspheres crosslinked with glutaraldehyde and rutin oriented to cosmetics
Graziola, F., Candido, T. M., Oliveira, C. A. D., Peres, D. D., Issa, M. G., Mota, J., Rosado, C., Consiglieri, V. O., Kaneko, T. M., Velasco, M. V. R., et al. (2016) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502016000400004 · Cited by 39
“…of, approximately, 25% in the process of obtaining microspheres can be mainly explained by the separation and removal of the low molecular weight gelatin in the supernatant of the emulsion when adding acetone, which is an agent that precipitates high molecular weight gelatin (Nahar et al., 2008).”
Background
Metadata
- Authors
- Nahar, M., Mishra, D., Dubey, V., & Jain, N. K.
- Venue
- Nanomedicine: Nanotechnology, Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 4
- Issue
- 3
- Pages
- 252-261
- ISSN
- 1549-9634 (ISSN-L)
- OpenAlex
- W2059356709
- Cited by
- 160
- References
- 0
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.